Hepatitis C
📧 Sign up to get email alerts when something new happens for Hepatitis C.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-09-16Clinical Trial Update: Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks in Adults With Chronic HCV Infection [Phase 3]
Phase 3 trial update of Sofosbuvir/Velpatasvir fixed-dose combination for 12 weeks in adults with chronic hepatitis C infection.
-
CLINICAL_TRIALS trial_result · 2016-09-16Clinical Trial Update: Drug Utilization of Boceprevir and Clinical Management of Health Outcomes of Interest in Chronic Hepatitis C Participants (P08518)
This completed clinical trial update reports on the utilization of Boceprevir and the clinical management of health outcomes in participants…
-
CLINICAL_TRIALS trial_result · 2016-09-16Clinical Trial Update: Safety and Efficacy of Sofosbuvir Plus Velpatasvir With or Without Ribavirin in Treatment-experienced Subjects With Chronic HCV Infection [Phase 2]
Phase 2 trial assessing sofobuvir plus velpatasvir with or without ribavirin in treatment-experienced chronic Hepatitis C patients; results …
-
CLINICAL_TRIALS trial_result · 2016-09-15Clinical Trial Update: Study of A Combination Pill With GS-7977 and GS-5885 for Hepatitis C in People With HIV [Phase 2]
Phase 2 study assessing a fixed-dose combination of sofosbuvir (GS-7977) and ledipasvir (GS-5885) for hepatitis C in people with HIV; the tr…
-
CLINICAL_TRIALS trial_result · 2016-09-15Clinical Trial Update: Safety and Efficacy of Sofosbuvir + Velpatasvir With or Without Ribavirin in Treatment-Naive Adults With Chronic HCV Infection [Phase 2]
Phase 2 trial evaluating sofobuvir/velpatasvir with or without ribavirin in treatment-naive chronic hepatitis C patients completed with post…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-09-15Clinical Trial Update: An Observational Study of Pegasys (Peginterferon Alfa-2a) Plus Ribavirin Based Regimens in Patients With Chronic Hepatitis C With Previous Treatment Failure
This clinical trial update indicates that an observational study of peginterferon alfa-2a (Pegasys) plus ribavirin-based regimens for chroni…
-
CLINICAL_TRIALS trial_result · 2016-09-13Clinical Trial Update: Safety and Biological Activity of InfraDure Biopump Secreting Sustained Interferon in HCV Patients [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating the safety and biological activity of the InfraDure Biopump delivering sustained interferon in patients …
-
CLINICAL_TRIALS trial_result · 2016-09-07Clinical Trial Update: Pegasys Long-Term Anti-Fibrotic Effect Co-Infection Trial (PERFECT) [Phase 3]
Phase 3 PERFECT trial evaluating Pegasys for long-term anti-fibrotic effects in HIV/HCV coinfection has been terminated.
-
CLINICAL_TRIALS trial_result · 2016-08-30Clinical Trial Update: Efficacy and Safety of Alisporivir Alone or Combined With RBV or PEG in Chronic Hepatitis C Genotype 2 and 3 Treatment-naïve Participants [Phase 2]
Phase 2 trial evaluating alisporivir alone or with ribavirin or pegylated interferon in treatment-naïve chronic hepatitis C patients with ge…
-
CLINICAL_TRIALS trial_result · 2016-08-29Clinical Trial Update: Ribavirin Bioavailability After Telaprevir Exposure
A pharmacokinetic study evaluating ribavirin bioavailability after exposure to telaprevir in patients with hepatitis C; the trial has comple…
-
CLINICAL_TRIALS trial_result · 2016-08-26Clinical Trial Update: Long Term Follow-up Study to Assess Durability of Sustained Virologic Response in Alisporivir-treated Hepatitis C Patients [Phase 3]
Phase 3 long-term follow-up study evaluating durability of sustained virologic response in alisporivir-treated Hepatitis C patients; results…
-
CLINICAL_TRIALS trial_result · 2016-08-26Clinical Trial Update: Anti-E1E2 Antibodies (D32.10 Epitope-binding Antibodies) and HCV Triple Therapy
This completed clinical trial evaluated anti-E1E2 epitope-binding antibodies in combination with HCV triple therapy for hepatitis C.
-
CLINICAL_TRIALS trial_result · 2016-08-25Clinical Trial Update: Efficacy and Safety of Adding Alisporivir (DEB025) to Peginterferon (IFN) Alfa-2a (Peg-IFN Alfa-2a) and Ribavirin in Chronic HCV Genotype 1 Patients Who Relapsed or Did Not Respond to Previous Treatment [Phase 2]
Phase 2 trial evaluating alisporivir added to peginterferon alfa-2a and ribavirin in chronic hepatitis C genotype 1 patients who relapsed or…
-
CLINICAL_TRIALS trial_result · 2016-08-24Clinical Trial Update: Vitamin D and Vitamin B12 Supplementation With Pegylated Interferon-Alfa Plus Ribavirin for Treating Chronic Hepatitis C [Phase 4]
Phase 4 trial assessing whether adding vitamin D and vitamin B12 to pegylated interferon-alfa plus ribavirin improves outcomes in chronic he…
-
CLINICAL_TRIALS trial_result · 2016-08-22Clinical Trial Update: Neutrino Regimen for Treatment-experienced HCV GT1 Patients [Phase 4]
Phase 4 clinical trial update indicating completed results for the Neutrino Regimen in treatment-experienced hepatitis C genotype 1 patients…
-
CLINICAL_TRIALS trial_result · 2016-08-18Clinical Trial Update: Telaprevir Open-Label Study in Co-Infected Patients [Phase 3]
This clinical trial update notes that the open-label Phase 3 study of telaprevir in patients co-infected with hepatitis C has completed.
-
CLINICAL_TRIALS trial_result · 2016-08-16Clinical Trial Update: Efficacy and Safety of Peg-Interferon Alpha-2a Plus Ribavirin in Genotype 1 Chronic Hepatitis C Participants Co-Infected With Human Immunodeficiency Virus [Phase 4]
A Phase 4 trial assessing the efficacy and safety of pegylated interferon alfa-2a plus ribavirin in genotype 1 chronic hepatitis C patients …
-
CLINICAL_TRIALS trial_result · 2016-08-15Clinical Trial Update: A Quality of Life Study of Peginterferon-Alfa-2a Plus Ribavirin in Participants With Chronic Hepatitis C and Persistently Normal Alanine Transaminase (ALT) Levels
This update reports quality-of-life results from a study of peginterferon alfa-2a plus ribavirin in participants with chronic hepatitis C an…
-
CLINICAL_TRIALS trial_result · 2016-08-11Clinical Trial Update: A Study of Peginterferon Alfa-2a (Pegasys) and Ribavirin (Copegus) Combination Therapy in Participants With Chronic Hepatitis C (CHC) and Various Degrees of Renal Impairment [Phase 4]
Phase 4 study evaluating peginterferon alfa-2a (Pegasys) in combination with ribavirin (Copegus) for chronic hepatitis C across varying degr…
-
CLINICAL_TRIALS trial_result · 2016-08-08Clinical Trial Update: Early Treatment With Sofosbuvir (SOF) and Ledipasvir (LDV) to Prevent HCV Recurrence After Liver Transplantation (OLT) [Phase 3]
A Phase 3 trial of sofosbuvir/ledipasvir in liver transplant recipients to prevent hepatitis C recurrence was terminated.
-
CLINICAL_TRIALS trial_result · 2016-08-08Clinical Trial Update: PROPHESYS 3: Observational Study on Predictors of Response in Patients With Treatment-naïve Chronic Hepatitis C Initiated on Treatment With Pegasys (Peginterferon Alfa-2a) or Peginterferon-alfa-2b
This is an observational PROPHESYS 3 study evaluating predictors of response in treatment-naïve chronic hepatitis C patients started on Pega…
-
CLINICAL_TRIALS trial_result · 2016-08-05Clinical Trial Update: A Study of Mericitabine in Combination With Boceprevir and Pegasys/Copegus in Patients With Chronic Hepatitis C [Phase 2]
A Phase 2 study evaluating mericitabine with boceprevir and Pegasys/Copegus in chronic hepatitis C has completed. The update does not provid…
-
CLINICAL_TRIALS trial_result · 2016-08-04Clinical Trial Update: A Study of Peginterferon Alfa-2a (Pegasys) When Administered in Combination With Ribavirin in Patients With Chronic Hepatitis C (CHC) [Phase 4]
A Phase 4 trial evaluating peginterferon alfa-2a (Pegasys) in combination with ribavirin for chronic hepatitis C has completed and posted re…
-
CLINICAL_TRIALS trial_result · 2016-08-04Clinical Trial Update: Sofosbuvir, Ribavirin, for the Treatment of Chronic Hepatitis C Virus Genotype 1 in HIV-Coinfected Patients Receiving Fixed Dose Co-formulation Emtricitabine/ Tenofovir/Cobicistat/Elvitegravir: A Pilot Study [Phase 4]
Phase 4 pilot study evaluating sofosbuvir plus ribavirin with a fixed-dose HIV antiretroviral co-formulation (elvitegravir/cobicistat/emtric…
-
CLINICAL_TRIALS trial_result · 2016-08-03Clinical Trial Update: Efficacy and Safety of Sofosbuvir+Ribavirin in Genotype 2 HCV-infected U.S. Veterans With Cirrhosis [Phase 4]
A Phase 4 trial update on the efficacy and safety of sofosbuvir plus ribavirin in genotype 2 hepatitis C patients with cirrhosis, conducted …